Vanguard Capital Management’s MAIA Biotechnology MAIA Stock Holding History
Bought
Maintained
Sold
Other funds holding MAIA
6CM
Vanguard Capital Management's MAIA Position: Q3 2026 in Review
Vanguard Capital Management held its MAIA Biotechnology (MAIA) position steady in Q3 2026 at 2,413,270 shares worth $2.85M. The position accounts for ﹤0.01% of the portfolio, ranked #3256.
Vanguard Capital Management first reported a position in MAIA in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.48M in Q2 2026. 44 funds tracked by Wall St. Rank hold MAIA as of Q3 2026.
- Vanguard Capital Management held 2,413,270 shares of MAIA Biotechnology worth $2.85M as of Q3 2026.
- Vanguard Capital Management left its MAIA Biotechnology share count unchanged in Q3 2026.
- MAIA Biotechnology made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3256 holding.
- Vanguard Capital Management first reported a position in MAIA Biotechnology in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's MAIA Biotechnology position peaked at $3.48M in Q2 2026.
- 44 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.